Trending

payers

Lilly collaborating with digital firm in ‘real world’ diabetes studies

Lilly collaborating with digital firm in ‘real world’ diabetes studies

Rivals Novo Nordisk, Sanofi, and AstraZeneca also offering digital health services.

X

Lilly collaborating with digital firm in ‘real world’ diabetes studies

https://pharmaphorum.com/views-and-analysis/lilly-collaborating-diabetes-firm-real-world-studies/

How to fix your adherence problem

How to fix your adherence problem

Typical patient support programs fail to improve adherence – and it’s costing the pharma industry billions. Here’s how

X

How to fix your adherence problem

https://pharmaphorum.com/partner-content-patients/fix-adherence-problem/

OECD calls for ‘rebalancing of power’ in drug price negotiations

OECD calls for ‘rebalancing of power’ in drug price negotiations

Health systems should fund more treatments for chronic diseases, says EFPIA

X

OECD calls for ‘rebalancing of power’ in drug price negotiations

https://pharmaphorum.com/news/oecd-calls-for-rebalancing-of-power-in-drug-price-negotiations/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com